Formulation of Sustained Release Chlorpheniramine maleate Matrix Tablets through Optimization and their Evaluation.

  • Masheer Ahmed Khan School of Pharmacy Devi Ahilya Vishwavidyalaya Takshshila Campus, Khandwa Road, Indore-452 001,India

Abstract

The object of the present study is to develop sustained release system of the antihistaminic agent Chlorpheniramine maleate generally used in allergic disorders, asthama, common cold and other conditions.  Matrix tablet is one of the least complicated devices to sustain the release of drug candidates. Different grades of polymers HPMC viz HPMCK4M and HPMCK15M were selected to sustain the release up to 12 hrs. Optimization techniques using factorial design for two factors at three levels (32 ) was selected to optimize varied response variables viz. release rate exponent (n), t50%, k, amount of drug released in 12h (Rel12h) and mean dissolution time MDT.  The optimum formulations were selected and the results obtained with the experimental values were compared with the predicted values. In conclusion, the results suggest that the developed sustained-release matrix tablets could provide quite regulated release of Chlorpheniramine maleate up to nearly 12 hr.

Downloads

Download data is not yet available.

Author Biography

Masheer Ahmed Khan, School of Pharmacy Devi Ahilya Vishwavidyalaya Takshshila Campus, Khandwa Road, Indore-452 001,India
Pharmacy
Crossmark
Statistics
582 Views | 464 Downloads
How to Cite
1.
Khan M. Formulation of Sustained Release Chlorpheniramine maleate Matrix Tablets through Optimization and their Evaluation. JDDT [Internet]. 15Sep.2012 [cited 26Apr.2024];2(5). Available from: https://www.jddtonline.info/index.php/jddt/article/view/281